Clinical Advances in Gastrointestinal Infections

Dear Colleagues,

Helicobacter pylori is the most prevalent chronic bacterial infection, with approximately half of the world's population estimated to be colonized. Along with the worldwide antibiotic resistance trends, eradication rates are declining, while resistance rates of H. pylori are increasing, and eradication is becoming increasingly difficult. The International Agency for Research on Cancer and the World Health Organization have classified H pylori as a class I carcinogen.

For the above reasons, H. pylori is the most important gastrointestinal infection; therefore, this Special Issue 'Clinical Advances in Gastrointestinal Infections' is dedicated to H. pylori infection. Following the COVID-19 pandemic and the widespread use of antibiotic therapies, we can expect new challenges in the treatment of H. pylori and the rise in antibiotic resistance.

The suggested topics for this Special Issue are:

- Challenges of treating a H. pylori infection following the COVID-19 pandemic.

Part of this Special Issue has been dedicated to COVID-19 infections, with the following topics:

- SARS-CoV-2-induced gastrointestinal diseases.

I hope that you will find the proposed topics suitable for the Special Issue 'Clinical Advances in Gastrointestinal Infections' in JCM.

Dr. Ivana Jukic
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• Helicobacter pylori
• antibiotic resistance
• prevalence
• treatment
• Maastricht VI/Florence consensus report
• pro-biotics
• COVID-19 pandemic